Ajooni Biotech Limited — Others, 04-02-2025: Shareholders meeting

Ajooni Biotech Limited has reported that all four resolutions from the Extra Ordinary General Meeting were passed with a requisite majority. Notable decisions include an increase in authorized share capital and the regularization of Mr. Ishtneet Bhatia as an Independent Director. The strong voting support, particularly from the promoter group (93.14% in favor), suggests solid backing for the company's strategic direction. This outcome may positively influence investor sentiment by demonstrating effective governance and growth potential, thereby presenting a constructive outlook for stakeholders.